Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against COVID-19. The study, by researchers at the University of York, builds on work conducted by ...

Osteoporosis is a disease in which bone resorbs faster than it is formed, gradually weakening its structure over time and ...

New medications that influence other areas of bone physiology are being explored and approved for postmenopausal osteoporosis. Some of the newer medications inhibit RANKL, which decrease bone ...

“Our findings suggest that injectable hydrogels with localized anti-catabolic drug delivery can complement systemic ...

In August, the FDA's Reproductive Health Drugs Advisory Committee backed two treatment indications for denosumab (for bone loss in postmenopausal osteoporosis and in hormone ablation therapy for ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Fifty per cent of women and 20 per cent of men will break a bone due to osteoporosis in their lifetime, according to the ...

They were followed for a total of 10 years to see whether the drug protected their bone health. Results showed that women who ...

Although most of the data was with omeprazole, this drug-induced condition is thought ... II diabetes in women that are at high risk for osteoporosis and fractures. Mechanism of Action The ...